Sun Ning, Shi Guang-Xia, Tu Jian-Feng, Li Yong-Ting, Zhang Li-Wen, Cao Yan, Du Yi, Zhao Jing-Jie, Xiong Da-Chang, Hou Hai-Kun, Liu Cun-Zhi
Department of Acupuncture and Moxibustion, Beijing Hospital of Traditional Chinese Medicine affiliated to Capital Medical University, Beijing, China.
Department of Medicine, School of Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China.
BMJ Open. 2016 Dec 13;6(12):e013830. doi: 10.1136/bmjopen-2016-013830.
Knee osteoarthritis (KOA) is one of the most common musculoskeletal disorders. Acupuncture is a popular form of complementary medicine for musculoskeletal conditions, although the evidence is inconclusive. Our objective is to evaluate the efficacy of traditional Chinese acupuncture for pain relief and function improvement in mild-to-moderate knee osteoarthritis (TCAKOA) participants.
METHODS/ANALYSIS: 42 patients will be recruited who have been diagnosed with mild-to-moderate KOA and randomly allocated in equal proportions to traditional Chinese acupuncture or minimal acupuncture. They will receive acupuncture for 24 sessions over 8 weeks. The primary end point is success rate, which will be calculated according to a change from baseline in Western Ontario and McMaster Universities Osteoarthritis Index pain and function scores at 8 weeks. Secondary end points include pain and function measurement, global change, the quality of life and the use of non-steroidal anti-inflammatory drugs (Celebrex, Pfizer) at 8, 16 and 26 weeks.
Ethical approval of this study has been granted by the Research Ethical Committee of Beijing Hospital of Traditional Chinese Medicine Affiliated to Capital Medical University (permission number: 2016BL-010-02). Written informed consent will be obtained from all participants. Outcomes of the trial will be disseminated through peer-reviewed publications.
ISRCTN14016893; Pre-results.
膝骨关节炎(KOA)是最常见的肌肉骨骼疾病之一。针灸是治疗肌肉骨骼疾病的一种流行的补充医学形式,尽管证据尚无定论。我们的目的是评估传统中医针灸对轻至中度膝骨关节炎(TCAKOA)患者缓解疼痛和改善功能的疗效。
方法/分析:将招募42名被诊断为轻至中度KOA的患者,并将他们以相等比例随机分配到传统中医针灸组或微针组。他们将在8周内接受24次针灸治疗。主要终点是成功率,将根据8周时西安大略和麦克马斯特大学骨关节炎指数疼痛和功能评分相对于基线的变化来计算。次要终点包括8、16和26周时的疼痛和功能测量、整体变化、生活质量以及非甾体抗炎药(西乐葆,辉瑞公司)的使用情况。
本研究已获得首都医科大学附属北京中医医院研究伦理委员会的伦理批准(批准号:2016BL - 010 - 02)。将从所有参与者处获得书面知情同意书。试验结果将通过同行评审出版物进行传播。
ISRCTN14016893;预结果。